{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:31:27Z","timestamp":1772778687496,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>In recent years, the prevalence of infertility has significantly increased and has become a global reproductive health problem. The female ovarian reserves have been shown to decrease progressively with an increase in age. Besides, the rate of embryo implantation and clinical pregnancy also decreases. Traditional Chinese medicine has been widely applied in assisted reproductive technology. It is reported to have a significant influence on improving the quality of oocytes, improving endometrial receptivity, increasing clinical pregnancy rate, reducing pregnancy-related complications, etc. Therefore, this study will investigate the effect of Guilu Xian, a traditional Chinese medicine formula on IVF-ET outcome in older women with low prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and analysis<\/jats:title>\n                <jats:p>This trial is a prospective, multicenter, randomized double-blind clinical trial. A total of 120 infertile patients with low prognosis and receiving IVF or ICSI in 3 public hospitals in China will be randomly divided into two parallel groups: Guilu Xian group (<jats:italic>n<\/jats:italic> = 60) and placebo group (<jats:italic>n<\/jats:italic> = 60). Patients in both groups will be treated with antagonist regimens to promote ovulation, and all the patients will be required to take the medication from the 2nd to 4th day of the menstrual cycle to the day of egg retrieval. A comparison of the total number of oocytes obtained, the fertilization rate, clinical pregnancy rate, embryo quality, embryo implantation rate, and early spontaneous abortion rate between the experimental group and the placebo group will be performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trials Registry <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/edit.aspx?pid=47002&amp;htm=4\">ChiCTR1900028255<\/jats:ext-link>. Registered on 16 December 2019.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05867-5","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T10:05:44Z","timestamp":1639389944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of traditional Chinese medicine formula Guilu Xian on in vitro fertilization and embryo transfer outcome in older women with low prognosis: study protocol for a prospective, multicenter, randomized double-blind study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yingjie","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9723-1213","authenticated-orcid":false,"given":"Zhengao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"5867_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1152\/physrev.00023.2015","volume":"96","author":"J Hart Roger","year":"2016","unstructured":"Hart Roger J. Physiological aspects of female fertility: role of the environment, modern lifestyle, and genetics. J Physiol Rev. 2016;96:873\u2013909.","journal-title":"J Physiol Rev"},{"issue":"1","key":"5867_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1701-2163(16)35138-6","volume":"34","author":"JA Johnson","year":"2012","unstructured":"Johnson JA, Tough S, SOGC Genetics Committee. Delayed childbearing. J Obstet Gynaecol Can. 2012;34(1):80\u201393.","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"5867_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.23736\/S0031-0808.18.03511-5","volume":"61","author":"A Conforti","year":"2019","unstructured":"Conforti A, Esteves SC, Picarelli S, Iorio G, Rania E, Zullo F, et al. Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept. Panminerva Med. 2019;61(1):24\u20139.","journal-title":"Panminerva Med"},{"issue":"12","key":"5867_CR4","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1093\/humrep\/dep340","volume":"24","author":"M Brandes","year":"2009","unstructured":"Brandes M, van der Steen JO, Bokdam SB, Hamilton CJ, de Bruin JP, Nelen WL, et al. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population. Hum Reprod. 2009;24(12):3127\u201335.","journal-title":"Hum Reprod"},{"key":"5867_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fendo.2018.00461","volume":"9","author":"SC Esteves","year":"2018","unstructured":"Esteves SC, Roque M, Bedoschi GM, Conforti A, Humaidan P, Alviggi C. Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why. Front Endocrinol (Lausanne). 2018;9:461.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5867_CR6","doi-asserted-by":"crossref","unstructured":"Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS ONE (2010) 5:e8772. 10.1371","DOI":"10.1371\/journal.pone.0008772"},{"key":"5867_CR7","doi-asserted-by":"crossref","unstructured":"Sampo AV, Palena C, Ganzer L, Maccari V, Estofan G, Hernandez M. The adverse effect of overweight in assisted reproduction treatment outcomes. JBRA Assist Reprod (2017) 21:212\u2013216. 10.5935","DOI":"10.5935\/1518-0557.20170041"},{"key":"5867_CR8","doi-asserted-by":"crossref","unstructured":"Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, et al. . Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod BioMed Online (2011) 22:S67\u2013S6e. 10.1016","DOI":"10.1016\/S1472-6483(11)60011-4"},{"key":"5867_CR9","doi-asserted-by":"crossref","unstructured":"Alviggi C, Conforti A, Caprio F, Gizzo S, Noventa M, Strina I, et al. Is estimated good prognosis patients could unexpected \u201chyporesponse\u201d to controlled ovarian stimulation be related to genetic polymorphisms of FSH receptors? Reprod Sci (2016) 23:1103\u20131108. 10.1177","DOI":"10.1177\/1933719116630419"},{"key":"5867_CR10","doi-asserted-by":"crossref","unstructured":"La Marca A, Papaleo E, Alviggi C, Ruvolo G, De Placido G, Candiani M, et al. . The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age. Hum Reprod (2013) 28:1369\u20131374. 10.1093","DOI":"10.1093\/humrep\/det061"},{"key":"5867_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fendo.2018.00461","volume":"9","author":"C Esteves Sandro","year":"2018","unstructured":"Esteves Sandro C, Matheus R, Bedoschi Giuliano M, et al. Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why. J Front Endocrinol (Lausanne). 2018;9:461.","journal-title":"J Front Endocrinol (Lausanne)"},{"key":"5867_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11306-019-1481-x","volume":"15","author":"CMM Antonietta","year":"2019","unstructured":"Antonietta CMM, Assunta I, Antonio SSC, et al. NMR metabolic profiling of follicular fluid for investigating the different causes of female infertility: a pilot study. J Metabolomics. 2019;15:19.","journal-title":"J Metabolomics"},{"issue":"02","key":"5867_CR13","first-page":"1","volume":"28","author":"W Zhang Haoqing","year":"2015","unstructured":"Zhang Haoqing W, Jingjing DG. Discussion on the Compatibility Rationality of Guilu Erxian Jiao Core. J Res Traditional Chinese Med. 2015;28(02):1\u20133.","journal-title":"J Res Traditional Chinese Med"},{"issue":"3","key":"5867_CR14","first-page":"163","volume":"18","author":"Z Yun","year":"2009","unstructured":"Yun Z. Experience in the treatment of Postmenopausal and Postmenopausal Diseases with Guilu Erxian decoction. J China Ethnic Folk Med. 2009;18(3):163.","journal-title":"J China Ethnic Folk Med"},{"issue":"17","key":"5867_CR15","first-page":"69","volume":"6","author":"W Zhaoli","year":"2014","unstructured":"Zhaoli W. Discussion on the syndrome and clinical application of Guilu Erxian ointment. J Clin Res Traditional Chinese Med. 2014;6(17):69\u201370.","journal-title":"J Clin Res Traditional Chinese Med"},{"issue":"3","key":"5867_CR16","first-page":"213","volume":"26","author":"G Hanlin","year":"2005","unstructured":"Hanlin G, Xiaoyang L. Tortoise deer Erxian gum was used to treat 60 cases of male semen abnormality. J Shaanxi Traditional Chinese Med. 2005;26(3):213\u20134.","journal-title":"J Shaanxi Traditional Chinese Med"},{"issue":"3","key":"5867_CR17","first-page":"59","volume":"26","author":"Y Enxi","year":"1995","unstructured":"Enxi Y. 826 cases of impotence were treated with modified Guilu Erxian decoction. J Fujian Traditional Chinese Med. 1995;26(3):59\u201360.","journal-title":"J Fujian Traditional Chinese Med"},{"key":"5867_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3389\/fendo.2019.00642","volume":"10","author":"L Yuan","year":"2019","unstructured":"Yuan L, Xiaofeng L, Yang X, et al. in vitroCumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of Fertilization\/Intracytoplasmic Sperm Injection. J Front Endocrinol (Lausanne). 2019;10:642.","journal-title":"J Front Endocrinol (Lausanne)"},{"key":"5867_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","volume":"62","author":"VB M\u00e9lodie","year":"2018","unstructured":"M\u00e9lodie VB, Christine W. Fertility and infertility: Definition and epidemiology. J Clin Biochem. 2018;62:2\u201310.","journal-title":"J Clin Biochem"},{"issue":"1","key":"5867_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","volume":"10","author":"D Moher","year":"2012","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10(1):28\u201355.","journal-title":"Int J Surg"},{"issue":"9","key":"5867_CR21","first-page":"625","volume":"7","author":"W T-X","year":"2007","unstructured":"T-X W, LY-P Z-XB, Ting-qian L, Jing L, Dagenais S, Moher D, et al. Consolidated Standards for Reporting Trials of Traditional Chinese Medicine (CONSORT for TCM). J Chin Evid Based Med. 2007;7(9):625\u201330.","journal-title":"J Chin Evid Based Med"},{"issue":"11","key":"5867_CR22","first-page":"5410","volume":"34","author":"W Ming Zhangshu","year":"2019","unstructured":"Ming Zhangshu W, Xiaohua WQ, Zhongbo X, Xiaoyong C. Effect of Jiawei Guilu Erxian decoction on the expression of miR-190 in ovary of mice with primary ovarian insufficiency. J Chinese J Traditional Chinese Med. 2019;34(11):5410\u20134.","journal-title":"J Chinese J Traditional Chinese Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05867-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05867-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05867-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T09:07:39Z","timestamp":1665479259000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05867-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["5867"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05867-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,13]]},"assertion":[{"value":"14 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Central ethical approval has been confirmed from Health Authorities and Ethics Committees of the Affiliated Hospital of Shandong University of TCM (ref approval no. SDTCM20191216). A detailed description of each participant will receive a test, and will receive each participant\u2019s informed consent in writing. The test plan of the \u201cdeclaration of Helsinki\u201d and international coordination meetings the principle of \u201cgood clinical practice guidelines.\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"917"}}